Cargando...
Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins
For myocarditis and inflammatory cardiomyopathy, an etiologically driven treatment is today the best option beyond heart failure therapy. Prerequisites for this are noninvasive and invasive biomarkers including endomyocardial biopsy and polymerase chain reaction on cardiotropic agents. Imaging by Do...
Guardado en:
| Publicado en: | Herz |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Medizin
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096625/ https://ncbi.nlm.nih.gov/pubmed/29947834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00059-018-4719-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|